Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 7
1974 4
1975 11
1976 14
1977 14
1978 21
1979 11
1980 13
1981 10
1982 17
1983 17
1984 19
1985 14
1986 11
1987 22
1988 25
1989 21
1990 13
1991 25
1992 27
1993 31
1994 31
1995 23
1996 24
1997 29
1998 21
1999 19
2000 19
2001 36
2002 45
2003 31
2004 28
2005 33
2006 41
2007 36
2008 42
2009 39
2010 44
2011 45
2012 39
2013 69
2014 70
2015 71
2016 77
2017 90
2018 92
2019 70
2020 140
2021 164
2022 129
2023 70
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

1,931 results

Results by year

Filters applied: . Clear all
Page 1
HIV vaccinology: 2021 update.
Lee JH, Crotty S. Lee JH, et al. Semin Immunol. 2021 Jan;51:101470. doi: 10.1016/j.smim.2021.101470. Epub 2021 Jul 14. Semin Immunol. 2021. PMID: 34272086 Free PMC article. Review.
Monoclonal antibody therapies against SARS-CoV-2.
Focosi D, McConnell S, Casadevall A, Cappello E, Valdiserra G, Tuccori M. Focosi D, et al. Lancet Infect Dis. 2022 Nov;22(11):e311-e326. doi: 10.1016/S1473-3099(22)00311-5. Epub 2022 Jul 5. Lancet Infect Dis. 2022. PMID: 35803289 Free PMC article. Review.
Advances in the progress of monoclonal antibodies for rabies.
Fan L, Zhang L, Li J, Zhu F. Fan L, et al. Hum Vaccin Immunother. 2022 Dec 31;18(1):2026713. doi: 10.1080/21645515.2022.2026713. Epub 2022 Feb 16. Hum Vaccin Immunother. 2022. PMID: 35172707 Free PMC article. Review.
Broadly neutralizing antibodies against COVID-19.
Zhou D, Ren J, Fry EE, Stuart DI. Zhou D, et al. Curr Opin Virol. 2023 Aug;61:101332. doi: 10.1016/j.coviro.2023.101332. Epub 2023 Jun 6. Curr Opin Virol. 2023. PMID: 37285620 Free PMC article. Review.
Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies.
Almagro JC, Mellado-Sánchez G, Pedraza-Escalona M, Pérez-Tapia SM. Almagro JC, et al. Int J Mol Sci. 2022 Aug 28;23(17):9763. doi: 10.3390/ijms23179763. Int J Mol Sci. 2022. PMID: 36077159 Free PMC article. Review.
Pharmacotherapeutics of SARS-CoV-2 Infections.
Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, Soni D, Das S, Hasan M, Patel M, Senan AM, Gorantla S, McMillan J, Edagwa B, Eisenberg R, Gurumurthy CB, Reid SPM, Punyadeera C, Chang L, Gendelman HE. Kevadiya BD, et al. J Neuroimmune Pharmacol. 2021 Mar;16(1):12-37. doi: 10.1007/s11481-020-09968-x. Epub 2021 Jan 6. J Neuroimmune Pharmacol. 2021. PMID: 33403500 Free PMC article. Review.
Editorial overview: Viral immunology.
de la Torre JC, Teijaro J. de la Torre JC, et al. Curr Opin Virol. 2019 Feb;34:vii-viii. doi: 10.1016/j.coviro.2019.03.003. Curr Opin Virol. 2019. PMID: 31006423 No abstract available.
Next-generation bNAbs for HIV-1 cure strategies.
Schriek AI, Aldon YLT, van Gils MJ, de Taeye SW. Schriek AI, et al. Antiviral Res. 2024 Feb;222:105788. doi: 10.1016/j.antiviral.2023.105788. Epub 2023 Dec 28. Antiviral Res. 2024. PMID: 38158130 Free article. Review.
1,931 results